Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
Kusuhara Y, Daizumoto K, Kawai K, Hirayama K, Kowada M, Shintani T, Fukuhara Y, Dondoo TO, Ozaki K, Tsuda M, Fukawa T, Nakatsuji H, Bando Y, Uehara H, Fukumori T, Takahashi M, Kanayama HO. Kusuhara Y, et al. Among authors: uehara h. Anticancer Res. 2019 Feb;39(2):703-711. doi: 10.21873/anticanres.13166. Anticancer Res. 2019. PMID: 30711948
Granulocyte colony-stimulating factor producing retroperitoneal leiomyosarcoma.
Fukuta K, Daizumoto K, Takahashi M, Mori H, Otomi Y, Uehara H, Fukawa T, Yamamoto Y, Yamaguchi K, Kanayama HO. Fukuta K, et al. Among authors: uehara h. IJU Case Rep. 2020 Dec 19;4(2):75-78. doi: 10.1002/iju5.12243. eCollection 2021 Mar. IJU Case Rep. 2020. PMID: 33718809 Free PMC article.
[A Case of Pappilary Renal Cell Caircinoma which Responded Well to the Combination Therapy of Ipilimumab and Nivolumab --A CASE REPORT-].
Fukatani Y, Daizumoto K, Kadoriku F, Yamamoto H, Sasaki Y, Ozaki K, Ueno Y, Tuda M, Kusuhara Y, Fukawa T, Yamamoto Y, Yamaguchi K, Takahashi M, Kanayama H, Niki M, Uehara H. Fukatani Y, et al. Among authors: uehara h. Hinyokika Kiyo. 2022 Apr;68(4):107-111. doi: 10.14989/ActaUrolJap_68_4_107. Hinyokika Kiyo. 2022. PMID: 35613898 Free article. Japanese.
ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.
Okura N, Nishioka N, Yamada T, Taniguchi H, Tanimura K, Katayama Y, Yoshimura A, Watanabe S, Kikuchi T, Shiotsu S, Kitazaki T, Nishiyama A, Iwasaku M, Kaneko Y, Uchino J, Uehara H, Horinaka M, Sakai T, Tanaka K, Kozaki R, Yano S, Takayama K. Okura N, et al. Among authors: uehara h. Clin Cancer Res. 2020 May 1;26(9):2244-2256. doi: 10.1158/1078-0432.CCR-19-2321. Epub 2020 Jan 17. Clin Cancer Res. 2020. PMID: 31953310
881 results